The Japanese Biochemical Society/The Molecular Biology Society of Japan

4:45 PM - 6:45 PM

[1P1029] HIF2-alpha is advisable therapeutic target for renal cell carcinomas.

〇Takahiro Isono1, Tokuhiro Chano2, Takeshi Yuasa3 (1.Central Res. Lab., Shiga Univ. Med. Science, 2.Dep. of Clin. Lab. Med, Shiga Univ. Med. Scien, 3.Dept. of Urol, Cancer Inst. Hosp., JFCR)

renal cell carcinomas, HIF, deprivation-resistant cells

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password